Are you Dr. Srinivasan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
9000 Rockville Pike
Bldg 10 Crc Room 2-5950
Bethesda, MD 20892Phone+1 301-496-6353Fax+1 301-402-0922
Summary
- Dr. Ramaprasad Srinivasan, MD is a general surgeon in Bethesda, Maryland. He is currently licensed to practice medicine in Virginia.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1997 - 1999
Stony Brook Medicine/University HospitalInternship, Internal Medicine, 1996 - 1997
Bangalore Medical CollegeClass of 1991
Certifications & Licensure
VA State Medical License 2000 - 2024
Clinical Trials
- Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome Start of enrollment: 2002 Jul 30
- Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M... Start of enrollment: 2010 Apr 01
- A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer Start of enrollment: 2010 May 06
- Join now to see all
Publications & Presentations
PubMed
- 867 citationsComprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.W. Marston Linehan, Paul T. Spellman, Christopher J. Ricketts, Chad J. Creighton, Suzanne S. Fei
The New England Journal of Medicine. 2016-01-14 - 155 citationsThe Metabolic Basis of Kidney Cancer.W. Marston Linehan, Laura S. Schmidt, Daniel R. Crooks, Darmood Wei, Ramaprasad Srinivasan
Cancer Discovery. 2019-05-14 - 340 citationsPhase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell CarcinomaToni K. Choueiri, Ulka N. Vaishampayan, Jonathan E. Rosenberg, Theodore F. Logan, Andrea L. Harzstark
Journal of Clinical Oncology. 2013-01-10
Press Mentions
Belzutifan Active in Von Hippel-Lindau Disease-Associated Renal Cell CarcinomaNovember 24th, 2021- No Benefit with Adjuvant Sorafenib in intermediate-/high-risk RCCNovember 2nd, 2020
